ホームSHPMY • OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
$8.24
9月27日, 20:10:00 GMT-4 · USD · OTCMKTS · 免責条項
米国 上場銘柄
前日の終値
$6.99
日次変動幅
$7.32 - $8.24
年間変動幅
$5.96 - $8.36
時価総額
767.35億 HKD
平均取引高
2090.00
市場ニュース
財務情報
損益計算書
収益
純利益
(CNY)2024年6月前年比変化率
収益
692.60億4.36%
営業費用
55.38億-6.12%
純利益
14.00億28.15%
純利益率
2.0222.42%
1 株当たりの収益
EBITDA
28.76億-1.59%
実効税率
28.00%
総資産
負債総額
(CNY)2024年6月前年比変化率
現金および短期投資
448.19億4.78%
総資産
2213.36億3.76%
負債総額
1391.07億3.52%
純資産
822.29億
発行済み株式
37.04億
帳簿価格
0.37
総資産利益率
2.86%
資本利益率
4.54%
現金の純増減額
(CNY)2024年6月前年比変化率
純利益
14.00億28.15%
営業キャッシュ フロー
59.89億40.53%
投資キャッシュ フロー
1.91億137.65%
財務キャッシュ フロー
5.13億-37.35%
現金の純増減額
66.77億45.68%
フリー キャッシュ フロー
76.66億41.07%
概要
Shanghai Pharmaceuticals is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
設立
1994/01/18
ウェブサイト
従業員数
49,234
検索
検索をクリア
検索を終了
Google アプリ
メインメニュー